Literature DB >> 21956371

Effect of interval between transcatheter hepatic arterial embolization and radiofrequency ablation on ablated lesion size in a swine model.

Cao Guang1, Nobuyuki Kawai, Morio Sato, Isao Takasaka, Hiroki Minamiguchi, Shinya Sahara, Kouhei Nakata, Tetsuo Sonomura, Shintaro Shirai, Ichiro Mori, Renjie Yang.   

Abstract

PURPOSE: The aim of the study was to clarify the effect of the interval between transcatheter hepatic arterial embolization (TAE) with Lipiodol plus gelatin sponge particles and radiofrequency (RF) ablation on the extent of ablation.
MATERIALS AND METHODS: Eight healthy swine were divided into four groups: RF ablation (ablation only), RF ablation immediately after TAE (immediate ablation), RF ablation 3 days after TAE (3-day ablation), and RF ablation 6 days after TAE (6-day ablation). Five ablated lesions were created in each swine (10 per group). A 2-cm expandable LeVeen needle electrode was used for RF ablation. Ablated lesions are composed of an outer reddish zone and an inner whitish zone.
RESULTS: The average longest length of the major, intermediate, and minor axes and the volume in the immediate ablation, 3-day ablation, and 6-day ablation groups were significant longer and greater (1.52 and 1.52, 1.46 and 1.50, and 1.37 and 1.35 times greater in the red zone and the whitish area, respectively) than those in the ablation-only group (P < 0.05/3). Accumulation of Lipiodol was still noted in the hepatic sinusoids in the 3-day and 6-day ablation groups.
CONCLUSION: RF ablation delayed to 6 days following TAE produced larger ablation volumes than did RF ablation alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21956371     DOI: 10.1007/s11604-011-0611-9

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  25 in total

1.  Radiofrequency ablation in a pig liver model: effect of transcatheter arterial embolization on coagulation diameter and histologic characteristics.

Authors:  Kazuya Sugimori; Manabu Morimoto; Kazuhito Shirato; Atsushi Kokawa; Naohiko Tomita; Takafumi Saito; Akinori Nozawa; Masamichi Hara; Hisahiko Sekihara; Katsuaki Tanaka
Journal:  Hepatol Res       Date:  2002-10       Impact factor: 4.288

2.  Comparing the outcomes of radiofrequency ablation and surgery in patients with a single small hepatocellular carcinoma and well-preserved hepatic function.

Authors:  Sung Noh Hong; Sun-Young Lee; Moon Seok Choi; Joon Hyeok Lee; Kwang Cheol Koh; Seung Woon Paik; Byung Chul Yoo; Jong Chul Rhee; Dongil Choi; Hyo Keun Lim; Kwang-Woong Lee; Jae Won Joh
Journal:  J Clin Gastroenterol       Date:  2005-03       Impact factor: 3.062

3.  Effect of vascular occlusion on radiofrequency ablation of the liver: results in a porcine model.

Authors:  S B Chinn; F T Lee; G D Kennedy; C Chinn; C D Johnson; T C Winter; T F Warner; D M Mahvi
Journal:  AJR Am J Roentgenol       Date:  2001-03       Impact factor: 3.959

4.  Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents.

Authors:  H Ohishi; H Uchida; H Yoshimura; S Ohue; J Ueda; M Katsuragi; N Matsuo; Y Hosogi
Journal:  Radiology       Date:  1985-01       Impact factor: 11.105

5.  Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure.

Authors:  Takuya Iwamoto; Nobuyuki Kawai; Morio Sato; Hirohiko Tanihata; Isao Takasaka; Hiroki Minamiguchi; Shinya Sahara; Kouhei Nakata; Shintaro Shirai
Journal:  J Vasc Interv Radiol       Date:  2008-11       Impact factor: 3.464

6.  Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Masao Akeboshi; Katsuya Shiraki; Takeshi Nakano; Kan Takeda
Journal:  Oncol Rep       Date:  2004-01       Impact factor: 3.906

7.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

Authors:  Riccardo A Lencioni; Hans-Peter Allgaier; Dania Cioni; Manfred Olschewski; Peter Deibert; Laura Crocetti; Holger Frings; Joerg Laubenberger; Ina Zuber; Hubert E Blum; Carlo Bartolozzi
Journal:  Radiology       Date:  2003-05-20       Impact factor: 11.105

8.  Radiofrequency ablation in a porcine liver model: effects of transcatheter arterial embolization with iodized oil on ablation time, maximum output, and coagulation diameter as well as angiographic characteristics.

Authors:  Motoki Nakai; Morio Sato; Shinya Sahara; Nobuyuki Kawai; Hirohiko Tanihata; Masashi Kimura; Masaki Terada
Journal:  World J Gastroenterol       Date:  2007-05-28       Impact factor: 5.742

9.  Early-stage hepatocellular carcinoma: radiofrequency ablation combined with chemoembolization versus hepatectomy.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Haruyuki Takaki; Hajime Yokoi; Masanobu Usui; Hiroyuki Sakurai; Shuji Isaji; Katsuya Shiraki; Hiroyuki Fuke; Shinji Uemoto; Kan Takeda
Journal:  Radiology       Date:  2008-02-27       Impact factor: 11.105

10.  Surgical resection versus percutaneous radiofrequency ablation in the treatment of hepatocellular carcinoma on cirrhotic liver.

Authors:  Marco Vivarelli; Alfredo Guglielmi; Andrea Ruzzenente; Alessandro Cucchetti; Roberto Bellusci; Claudio Cordiano; Antonino Cavallari
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more
  4 in total

1.  Ablative zone size created by radiofrequency ablation with and without chemoembolization in small hepatocellular carcinomas.

Authors:  Takashi Yamanaka; Koichiro Yamakado; Haruyuki Takaki; Atsuhiro Nakatsuka; Katsuya Shiraki; Hiroshi Hasegawa; Yoshiyuki Takei; Kan Takeda
Journal:  Jpn J Radiol       Date:  2012-05-19       Impact factor: 2.374

2.  [National S3 guidelines on hepatocellular carcinoma].

Authors:  C M Sommer; U Stampfl; H U Kauczor; P L Pereira
Journal:  Radiologe       Date:  2014-07       Impact factor: 0.635

3.  Enhanced efficacy of radiofrequency ablation for hepatocellular carcinoma using a novel vascular disrupting agent, CKD-516.

Authors:  Su Jung Ham; YoonSeok Choi; Seul-I Lee; Jinil Kim; Young Il Kim; Jin Wook Chung; Kyung Won Kim
Journal:  Hepatol Int       Date:  2017-07-18       Impact factor: 6.047

4.  Radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of single hepatocellular carcinoma of 2 to 5 cm in diameter: comparison with surgical resection.

Authors:  Jin Woong Kim; Sang Soo Shin; Jae Kyu Kim; Sung Kyu Choi; Suk Hee Heo; Hyo Soon Lim; Young Hoe Hur; Chol Kyoon Cho; Yong Yeon Jeong; Heoung Keun Kang
Journal:  Korean J Radiol       Date:  2013-07-17       Impact factor: 3.500

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.